CoChat
Sign Up
Cited by 177

The DOI matches its Crossref record.

Lecithin: cholesterol acyltransferase – from biochemistry to role in cardiovascular disease

Rousset, Xavier, Vaisman, Boris, Amar, Marcelo, Sethi, Amar A, Remaley, Alan T·2009·Current Opinion in Endocrinology, Diabetes & Obesity
DOI 10.1097/med.0b013e328329233bPMC PMC2910390
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/med.0b013e328329233b

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 116

  1. Glomset, 1962, The mechanism of the plasma cholesterol esterification reaction: plasma fatty acid transferase, Biochim Biophys Acta, 65, 128, 10.1016/0006-3002(62)90156-7 · DOI
  2. Glomset, 1966, Role of plasma lecithin: cholesterol acyltransferase in the metabolism of high density lipoproteins, J Lipid Res, 7, 638, 10.1016/S0022-2275(20)39245-2 · DOI
  3. Glomset, 1968, The plasma lecithins: cholesterol acyltransferase reaction, J Lipid Res, 9, 155, 10.1016/S0022-2275(20)43114-1 · DOI
  4. Remaley, 2008, HDL-replacement therapy: mechanism of action, types of agents and potential clinical indications, Expert Rev Cardiovasc Ther, 6, 1203, 10.1586/14779072.6.9.1203 · DOI
  5. McLean, 1986, Cloning and expression of human lecithin-cholesterol acyltransferase cDNA, Proc Natl Acad Sci U S A, 83, 2335, 10.1073/pnas.83.8.2335 · DOI
  6. Warden, 1989, Tissue-specific expression, developmental regulation, and chromosomal mapping of the lecithin: cholesterol acyltransferase gene. Evidence for expression in brain and testes as well as liver, J Biol Chem, 264, 21573, 10.1016/S0021-9258(20)88222-2 · DOI
  7. Hixson, 1993, Baboon lecithin cholesterol acyltransferase (LCAT): cDNA sequences of two alleles, evolution, and gene expression, Gene, 128, 295, 10.1016/0378-1119(93)90578-Q · DOI
  8. Smith, 1990, Cellular localization of apolipoprotein D and lecithin: cholesterol acyltransferase mRNA in rhesus monkey tissues by in situ hybridization, J Lipid Res, 31, 995, 10.1016/S0022-2275(20)42739-7 · DOI
  9. Vaisman, 1995, Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice, J Biol Chem, 270, 12269, 10.1074/jbc.270.20.12269 · DOI
  10. Hoeg, 1996, Overexpression of lecithin: cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis, Proc Natl Acad Sci U S A, 93, 11448, 10.1073/pnas.93.21.11448 · DOI
  11. Hoeg, 1996, Lecithin: cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits, J Biol Chem, 271, 4396, 10.1074/jbc.271.8.4396 · DOI
  12. Albers, 1992, Cholesteryl ester transfer protein in human brain, Int J Clin Lab Res, 21, 264, 10.1007/BF02591657 · DOI
  13. Staels, 1992, Lecithin: cholesterol acyltransferase gene expression is regulated in a tissue-selective manner by fibrates, J Lipid Res, 33, 727, 10.1016/S0022-2275(20)41436-1 · DOI
  14. Homma, 1994, Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia, Atherosclerosis, 106, 191, 10.1016/0021-9150(94)90124-4 · DOI
  15. Yvan-Charvet, 2007, Inhibition of cholesteryl ester transfer protein by torcetrapib modestly increases macrophage cholesterol efflux to HDL, Arterioscler Thromb Vasc Biol, 27, 1132, 10.1161/ATVBAHA.106.138347 · DOI
  16. Mishra, 2005, The effect of atorvastatin on serum lipoproteins in acromegaly, Clin Endocrinol (Oxf), 62, 650, 10.1111/j.1365-2265.2005.02273.x · DOI
  17. Kassai, 2007, The effect of atorvastatin therapy on lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein and the antioxidant paraoxonase, Clin Biochem, 40, 1, 10.1016/j.clinbiochem.2006.05.016 · DOI
  18. Murata, 1996, Cloning of rabbit LCAT cDNA: increase in LCAT mRNA abundance in the liver of cholesterol-fed rabbits, J Lipid Res, 37, 1616, 10.1016/S0022-2275(20)39144-6 · DOI
  19. Peelman, 1997, Structural and functional properties of the 154-171 wild-type and variant peptides of human lecithin-cholesterol acyltransferase, Eur J Biochem, 249, 708, 10.1111/j.1432-1033.1997.t01-2-00708.x · DOI
  20. Yang, 1987, Lecithin: cholesterol acyltransferase. Functional regions and a structural model of the enzyme, J Biol Chem, 262, 3086, 10.1016/S0021-9258(18)61472-3 · DOI
  21. Adimoolam, 1998, Structural and functional properties of two mutants of lecithin-cholesterol acyltransferase (T123I and N228K), J Biol Chem, 273, 32561, 10.1074/jbc.273.49.32561 · DOI
  22. Peelman, 1998, A proposed architecture for lecithin cholesterol acyl transferase (LCAT): identification of the catalytic triad and molecular modeling, Protein Sci, 7, 587, 10.1002/pro.5560070307 · DOI
  23. Jin, 1999, Surface plasmon resonance biosensor studies of human wild-type and mutant lecithin cholesterol acyltransferase interactions with lipoproteins, Biochemistry, 38, 15659, 10.1021/bi9916729 · DOI
  24. Brasseur, 1997, Peptides in membranes: tipping the balance of membrane stability, Trends Biochem Sci, 22, 167, 10.1016/S0968-0004(97)01047-5 · DOI
  25. Francone, 1991, Effects of site-directed mutagenesis at residues cysteine-31 and cysteine-184 on lecithin-cholesterol acyltransferase activity, Proc Natl Acad Sci U S A, 88, 1716, 10.1073/pnas.88.5.1716 · DOI
  26. Miller, 1996, Glycosylation structure and enzyme activity of lecithin: cholesterol acyltransferase from human plasma, HepG2 cells, and baculoviral and Chinese hamster ovary cell expression systems, J Lipid Res, 37, 551, 10.1016/S0022-2275(20)37598-2 · DOI
  27. Ayyobi, 2000, Biochemical and compositional analyses of recombinant lecithin: cholesterol acyltransferase (LCAT) obtained from a hepatic source, Biochim Biophys Acta, 1484, 1, 10.1016/S1388-1981(99)00199-7 · DOI
  28. Francone, 1993, Lecithin-cholesterol acyltransferase: effects of mutagenesis at N-linked oligosaccharide attachment sites on acyl acceptor specificity, Biochim Biophys Acta, 1166, 301, 10.1016/0005-2760(93)90110-U · DOI
  29. Schindler, 1995, Site-specific detection and structural characterization of the glycosylation of human plasma proteins lecithin: cholesterol acyltransferase and apolipoprotein D using HPLC/electrospray mass spectrometry and sequential glycosidase digestion, Protein Sci, 4, 791, 10.1002/pro.5560040419 · DOI
  30. Francone, 1996, Effects of carboxy-terminal truncation on human lecithin: cholesterol acyltransferase activity, J Lipid Res, 37, 1609, 10.1016/S0022-2275(20)39143-4 · DOI
  31. Kosman, 2001, Deletion of specific glycan chains affects differentially the stability, local structures, and activity of lecithin-cholesterol acyltransferase, J Biol Chem, 276, 37230, 10.1074/jbc.M104326200 · DOI
  32. Subbaiah, 1980, Low density lipoprotein-activated lysolecithin acylation by human plasma lecithin-cholesterol acyltransferase. Identity of lysolecithin acyltransferase and lecithin-cholesterol acyltransferase, J Biol Chem, 255, 9275, 10.1016/S0021-9258(19)70558-4 · DOI
  33. Rajaram, 1985, Reactivity of human lipoproteins with purified lecithin: cholesterol acyltransferase during incubations in vitro, Biochim Biophys Acta, 835, 41, 10.1016/0005-2760(85)90028-1 · DOI · Paper page
  34. Grove, 1991, Comparative specificity of plasma lecithin: cholesterol acyltransferase from ten animal species, Lipids, 26, 416, 10.1007/BF02536066 · DOI
  35. Portman, 1964, Factors influencing the level and fatty acid specificity of the cholesterol esterification activity in human plasma, Arch Biochem Biophys, 105, 532, 10.1016/0003-9861(64)90048-7 · DOI
  36. Christiaens, 2000, Headgroup specificity of lecithin cholesterol acyltransferase for monomeric and vesicular phospholipids, Biochim Biophys Acta, 1486, 321, 10.1016/S1388-1981(00)00075-5 · DOI
  37. Bolin, 1996, Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding, J Biol Chem, 271, 19152, 10.1074/jbc.271.32.19152 · DOI
  38. Subbaiah, 1993, Incorporation of dietary n-3 fatty acids into molecular species of phosphatidyl choline and cholesteryl ester in normal human plasma, Am J Clin Nutr, 58, 360, 10.1093/ajcn/58.3.360 · DOI
  39. Rye, 1996, The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins, J Biol Chem, 271, 4243, 10.1074/jbc.271.8.4243 · DOI
  40. Sparks, 1989, The neutral lipid composition and size of recombinant high density lipoproteins regulates lecithin: cholesterol acyltransferase activity, Biochem Cell Biol, 67, 358, 10.1139/o89-056 · DOI
  41. Fielding, 1972, A protein cofactor of lecithin: cholesterol acyltransferase, Biochem Biophys Res Commun, 46, 1493, 10.1016/0006-291X(72)90776-0 · DOI
  42. Jonas, 1991, Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins, Biochim Biophys Acta, 1084, 205, 10.1016/0005-2760(91)90062-M · DOI
  43. Zhao, 2005, Apolipoprotein E is the major physiological activator of lecithin-cholesterol acyltransferase (LCAT) on apolipoprotein B lipoproteins, Biochemistry, 44, 1013, 10.1021/bi0481489 · DOI
  44. Alexander, 2005, Apolipoprotein A-I helix 6 negatively charged residues attenuate lecithin-cholesterol acyltransferase (LCAT) reactivity, Biochemistry, 44, 5409, 10.1021/bi047412v · DOI
  45. Sviridov, 2000, Identification of a sequence of apolipoprotein A-I associated with the activation of lecithin: cholesterol acyltransferase, J Biol Chem, 275, 19707, 10.1074/jbc.M000962200 · DOI
  46. Hoang, 2003, Natural mutations of apolipoprotein A-I impairing activation of lecithin: cholesterol acyltransferase, Biochim Biophys Acta, 1631, 72, 10.1016/S1388-1981(02)00357-8 · DOI
  47. Roosbeek, 2001, Three arginine residues in apolipoprotein A-I are critical for activation of lecithin: cholesterol acyltransferase, J Lipid Res, 42, 31, 10.1016/S0022-2275(20)32333-6 · DOI
  48. Winkler, 1990, Structure of human pancreatic lipase, Nature, 343, 771, 10.1038/343771a0 · DOI
  49. van Tilbeurgh, 1993, Interfacial activation of the lipase-procolipase complex by mixed micelles revealed by X-ray crystallography, Nature, 362, 814, 10.1038/362814a0 · DOI
  50. Peng, 2008, Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function, Arterioscler Thromb Vasc Biol, 28, 2063, 10.1161/ATVBAHA.108.173815 · DOI
  51. Davidson, 2007, The structure of apolipoprotein A-I in high density lipoproteins, J Biol Chem, 282, 22249, 10.1074/jbc.R700014200 · DOI
  52. May, 2007, The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions, Ann Med, 39, 219, 10.1080/07853890701214881 · DOI
  53. Schwartz, 2004, Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans, J Lipid Res, 45, 1594, 10.1194/jlr.M300511-JLR200 · DOI
  54. Maric, 2005, Intracellular lipidation of newly synthesized apolipoprotein A-I in primary murine hepatocytes, J Biol Chem, 280, 39942, 10.1074/jbc.M507733200 · DOI
  55. Bodzioch, 1999, The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease, Nat Genet, 22, 347, 10.1038/11914 · DOI · Paper page
  56. Brooks-Wilson, 1999, Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency, Nat Genet, 22, 336, 10.1038/11905 · DOI · Paper page
  57. Zannis, 2004, Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer, Curr Opin Lipidol, 15, 151, 10.1097/00041433-200404000-00008 · DOI · Paper page
  58. Wang, 2004, ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins, Proc Natl Acad Sci U S A, 101, 9774, 10.1073/pnas.0403506101 · DOI
  59. Acton, 1996, Identification of scavenger receptor SR-BI as a high density lipoprotein receptor, Science, 271, 518, 10.1126/science.271.5248.518 · DOI · Paper page
  60. Murao, 1997, Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes, J Biol Chem, 272, 17551, 10.1074/jbc.272.28.17551 · DOI
  61. Czarnecka, 1996, Regulation of cellular cholesterol efflux by lecithin: cholesterol acyltransferase reaction through nonspecific lipid exchange, J Biol Chem, 271, 2023, 10.1074/jbc.271.4.2023 · DOI
  62. Chajek, 1978, Isolation and characterization of a human serum cholesteryl ester transfer protein, Proc Natl Acad Sci U S A, 75, 3445, 10.1073/pnas.75.7.3445 · DOI
  63. Fielding, 1988, The human plasma cholesteryl ester transfer protein: structure, function and physiology, Adv Exp Med Biol, 243, 219, 10.1007/978-1-4613-0733-4_27 · DOI
  64. Francone, 1995, Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism, J Clin Invest, 96, 1440, 10.1172/JCI118180 · DOI
  65. Mehlum, 1995, Tissue-specific expression of the human gene for lecithin: cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profile, Eur J Biochem, 230, 567, 10.1111/j.1432-1033.1995.tb20597.x · DOI
  66. Sakai, 1997, Targeted disruption of the mouse lecithin: cholesterol acyltransferase (LCAT) gene. Generation of a new animal model for human LCAT deficiency, J Biol Chem, 272, 7506, 10.1074/jbc.272.11.7506 · DOI
  67. Ng, 1997, Disruption of the murine lecithin: cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I, J Biol Chem, 272, 15777, 10.1074/jbc.272.25.15777 · DOI
  68. Foger, 1999, Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice, J Biol Chem, 274, 36912, 10.1074/jbc.274.52.36912 · DOI
  69. Berard, 1997, High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase, Nat Med, 3, 744, 10.1038/nm0797-744 · DOI
  70. Brousseau, 1997, Overexpression of human lecithin: cholesterol acyltransferase in cholesterol-fed rabbits: LDL metabolism and HDL metabolism are affected in a gene dose-dependent manner, J Lipid Res, 38, 2537, 10.1016/S0022-2275(20)30038-9 · DOI
  71. Brousseau, 2000, LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits, Arterioscler Thromb Vasc Biol, 20, 450, 10.1161/01.ATV.20.2.450 · DOI
  72. Mehlum, 2000, Overexpression of human lecithin: cholesterol acyltransferase in mice offers no protection against diet-induced atherosclerosis, APMIS, 108, 336, 10.1034/j.1600-0463.2000.d01-65.x · DOI
  73. Furbee, 2002, Transgenic overexpression of human lecithin: cholesterol acyltransferase (LCAT) in mice does not increase aortic cholesterol deposition, Atherosclerosis, 165, 89, 10.1016/S0021-9150(02)00201-0 · DOI
  74. Lambert, 2001, Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice, J Biol Chem, 276, 15090, 10.1074/jbc.M008466200 · DOI
  75. Zhu, 2004, A novel in vivo lecithin-cholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy, Am J Pathol, 165, 1269, 10.1016/S0002-9440(10)63386-X · DOI
  76. Forte, 1999, Targeted disruption of the murine lecithin: cholesterol acyltransferase gene is associated with reductions in plasma paraoxonase and platelet-activating factor acetylhydrolase activities but not in apolipoprotein J concentration, J Lipid Res, 40, 1276, 10.1016/S0022-2275(20)33489-1 · DOI
  77. Furbee, 2002, Lecithin: cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice, J Biol Chem, 277, 3511, 10.1074/jbc.M109883200 · DOI
  78. Ng, 2002, Oxidative stress is markedly elevated in lecithin: cholesterol acyltransferase-deficient mice and is paradoxically reversed in the apolipoprotein E knockout background in association with a reduction in atherosclerosis, J Biol Chem, 277, 11715, 10.1074/jbc.M112320200 · DOI
  79. Calabresi, 2005, The molecular basis of lecithin: cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families, Arterioscler Thromb Vasc Biol, 25, 1972, 10.1161/01.ATV.0000175751.30616.13 · DOI
  80. Kuivenhoven, 1997, The molecular pathology of lecithin: cholesterol acyltransferase (LCAT) deficiency syndromes, J Lipid Res, 38, 191, 10.1016/S0022-2275(20)37433-2 · DOI
  81. Gjone, 1968, Familial serum cholesterol ester deficiency. Clinical study of a patient with a new syndrome, Acta Med Scand, 183, 107, 10.1111/j.0954-6820.1968.tb10449.x · DOI
  82. Norum, 1967, Familial serum-cholesterol esterification failure. A new inborn error of metabolism, Biochim Biophys Acta, 144, 698, 10.1016/0005-2760(67)90064-1 · DOI
  83. Carlson, 1979, Fish-eye disease. A new familial condition with massive corneal opacities and dyslipoproteinaemia, Lancet, 2, 922
  84. Carlson, 1985, Paradoxical esterification of plasma cholesterol in fish eye disease, Acta Med Scand, 217, 491, 10.1111/j.0954-6820.1985.tb03252.x · DOI
  85. O K, Hill, 1993, Recombinant lecithin: cholesterol acyltransferase containing a Thr123-Ile mutation esterifies cholesterol in low density lipoprotein but not in high density lipoprotein., J Lipid Res, 34, 81, 10.1016/S0022-2275(20)41321-5 · DOI
  86. Klein, 1995, In vitro expression of structural defects in the lecithin-cholesterol acyltransferase gene, J Biol Chem, 270, 9443, 10.1074/jbc.270.16.9443 · DOI
  87. Klein, 1993, Fish eye syndrome: a molecular defect in the lecithin-cholesterol acyltransferase (LCAT) gene associated with normal alpha-LCAT-specific activity. Implications for classification and prognosis, J Clin Invest, 92, 479, 10.1172/JCI116591 · DOI
  88. Kuivenhoven, 1995, A unique genetic and biochemical presentation of fish-eye disease, J Clin Invest, 96, 2783, 10.1172/JCI118348 · DOI
  89. Funke, 1991, A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity, Proc Natl Acad Sci U S A, 88, 4855, 10.1073/pnas.88.11.4855 · DOI
  90. Kuivenhoven, 1996, An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease), J Clin Invest, 98, 358, 10.1172/JCI118800 · DOI
  91. Ayyobi, 2004, Lecithin: cholesterol acyltransferase (LCAT) deficiency and risk of vascular disease: 25 year follow-up, Atherosclerosis, 177, 361, 10.1016/j.atherosclerosis.2004.07.018 · DOI
  92. Nofer, 2005, Tangier disease: still more questions than answers, Cell Mol Life Sci, 62, 2150, 10.1007/s00018-005-5125-0 · DOI
  93. Panescu, 1997, Recurrence of lecithin cholesterol acyltransferase deficiency after kidney transplantation, Nephrol Dial Transplant, 12, 2430, 10.1093/ndt/12.11.2430 · DOI
  94. Aranda, 2008, Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs), Clin Nephrol, 69, 213, 10.5414/CNP69213 · DOI
  95. Kuivenhoven, 1996, Two novel molecular defects in the LCAT gene are associated with fish eye disease, Arterioscler Thromb Vasc Biol, 16, 294, 10.1161/01.ATV.16.2.294 · DOI
  96. Owen, 1996, Complete deficiency of plasma lecithin-cholesterol acyltransferase (LCAT) activity due to a novel homozygous mutation (Gly-30-Ser) in the LCAT gene, Hum Mutat, 8, 79, 10.1002/(SICI)1098-1004(1996)8:1<79::AID-HUMU13>3.0.CO;2-O · DOI
  97. Wiebusch, 1995, Deficiency of lecithin: cholesterol acyltransferase due to compound heterozygosity of two novel mutations (Gly33Arg and 30 bp ins) in the LCAT gene, Hum Mol Genet, 4, 143, 10.1093/hmg/4.1.143 · DOI
  98. Yang, 1997, Catalytically inactive lecithin: cholesterol acyltransferase (LCAT) caused by a Gly 30 to Ser mutation in a family with LCAT deficiency, J Lipid Res, 38, 585, 10.1016/S0022-2275(20)37266-7 · DOI
  99. Scarpioni, 2008, Dramatic atherosclerotic vascular burden in a patient with familial lecithin-cholesterol acyltransferase (LCAT) deficiency, Nephrol Dial Transplant, 23, 1074, 10.1093/ndt/gfm760 · DOI
  100. Berard, 2001, A normal rate of cellular cholesterol removal can be mediated by plasma from a patient with familial lecithin-cholesterol acyltransferase (LCAT) deficiency, Clin Chim Acta, 314, 131, 10.1016/S0009-8981(01)00689-1 · DOI
  101. Hovingh, 2005, Inherited disorders of HDL metabolism and atherosclerosis, Curr Opin Lipidol, 16, 139, 10.1097/01.mol.0000162318.47172.ef · DOI
  102. Hovingh, 2005, Compromised LCAT function is associated with increased atherosclerosis, Circulation, 112, 879, 10.1161/CIRCULATIONAHA.105.540427 · DOI
  103. Kastelein, 1992, Familial high-density-lipoprotein deficiency causing corneal opacities (fish eye disease) in a family of Dutch descent, J Intern Med, 231, 413, 10.1111/j.1365-2796.1992.tb00953.x · DOI
  104. Zhang, 2004, Novel P143L polymorphism of the LCAT gene is associated with dyslipidemia in Chinese patients who have coronary atherosclerotic heart disease, Biochem Biophys Res Commun, 318, 4, 10.1016/j.bbrc.2004.03.177 · DOI
  105. Pare, 2007, Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol, Am J Hum Genet, 80, 673, 10.1086/513286 · DOI
  106. Spirin, 2007, Common single-nucleotide polymorphisms act in concert to affect plasma levels of high-density lipoprotein cholesterol, Am J Hum Genet, 81, 1298, 10.1086/522497 · DOI
  107. Dullaart, 2008, Plasma lecithin: cholesterol acyltransferase activity is elevated in metabolic syndrome and is an independent marker of increased carotid artery intima media thickness, J Clin Endocrinol Metab, 93, 4860, 10.1210/jc.2008-1213 · DOI
  108. Wells, 1986, Lecithin: cholesterol acyltransferase and lysolecithin in coronary atherosclerosis, Exp Mol Pathol, 45, 303, 10.1016/0014-4800(86)90019-5 · DOI
  109. Ruhling, 1999, Net mass transfer of plasma cholesteryl esters and lipid transfer proteins in normolipidemic patients with peripheral vascular disease, Metabolism, 48, 1361, 10.1016/S0026-0495(99)90144-0 · DOI
  110. Solajic-Bozicevic, 1991, Lecithin: cholesterol acyltransferase activity in patients with acute myocardial infarction and coronary heart disease, Artery, 18, 326
  111. Solajic-Bozicevic, 1994, Lecithin-cholesterol acryltransferase activity in patients with coronary artery disease examined by coronary angiography, Clin Invest, 72, 951, 10.1007/BF00577734 · DOI
  112. Miida, 1996, Pre beta 1-high-density lipoprotein increases in coronary artery disease, Clin Chem, 42, 1992, 10.1093/clinchem/42.12.1992 · DOI
  113. Dobiasova, 1996, Measurement of fractional esterification rate of cholesterol in plasma depleted of apoprotein B containing lipoprotein: methods and normal values, Physiol Res, 45, 65
  114. Frohlich, 2003, Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography, Clin Chem, 49, 1873, 10.1373/clinchem.2003.022558 · DOI
  115. Murayama, 1984, Effects of plasma infusion on plasma lipids, apoproteins and plasma enzyme activities in familial lecithin: cholesterol acyltransferase deficiency, Eur J Clin Invest, 14, 122, 10.1111/j.1365-2362.1984.tb02100.x · DOI
  116. Norum, 1968, The effect of plasma transfusion on the plasma cholesterol esters in patients with familial plasma lecithin: cholesterol acyltransferase deficiency, Scand J Clin Lab Invest, 22, 339, 10.3109/00365516809167071 · DOI

Cited by

Sorted by citations

See all 177

Metadata

Authors
Rousset, X., Vaisman, B., Amar, M., Sethi, A. A., & Remaley, A. T.
Venue
Current Opinion in Endocrinology, Diabetes & Obesity
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2009-04
Volume
16
Issue
2
Pages
163-171
ISSN
1752-296X
DOI
10.1097/med.0b013e328329233b
PMC
PMC2910390
Cited by
177
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lecithin: cholesterol acyltransferase – from biochemistry to role in cardiovascular disease. https://app.cochat.ai/papers/10.1097/med.0b013e328329233b
The paper
Rousset, X., Vaisman, B., Amar, M., Sethi, A. A., & Remaley, A. T. (2009). Lecithin: cholesterol acyltransferase – from biochemistry to role in cardiovascular disease. Current Opinion in Endocrinology, Diabetes & Obesity. https://doi.org/10.1097/med.0b013e328329233b